While eIF4E elevation is well known to contribute to multiple cancer phenotypes19,55,56, recent studies have also implicated increased NCBP2 levels as a contributor to malignancy43,57,58 supporting the biomedical relevance of this regulatory point. The gene discussed is NCBP2; the disease is cancer.